MALAT1 has been shown to modulate key regulatory pathways involved in lipid homeostasis, including the regulation of lipogenesis and lipid oxidation [34,35], making it a potential player in the pathogenesis of hepatic steatosis and related metabolic disorders. Here, MALAT1 is linked to metabolic disease.